PeptidePedia The community reference

Flourishglobal Peptide Biotech: difference between revisions

Diff·revision 8 → 9·06:57, 28 Mar 2025

Difference between revision 8 and revision 9 of Flourishglobal Peptide Biotech. 6 lines changed; the page grew by 1,443 bytes.

Revision 8 — 03:59, 21 Mar 2025
VerifyFirstVida (talk)
expand §Operations and documentation practice
2,841 bytes ±0
Revision 9 — 06:57, 28 Mar 2025
PurityClaimPia (talk)
rm unsourced claim per PP:V
4,284 bytes +1,443
10The organisation is one of twenty covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}}10The organisation is one of twenty covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}}
1111
+12This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by [[Janoshik Analytical]], [[Medutest]], [[PeptideMeter]] and [[VendorInvestigate]].{{r|tally}}
+13
12== Corporate identity and history ==14== Corporate identity and history ==
13Incorporated in 2019 in Chengdu, the organisation is one of two covered here that are based outside the eastern coastal cluster, the other being in Hunan.{{r|registry}} Its registered name includes "Peptide Biotech", making it one of the few whose registration matches its trading activity closely.15Incorporated in 2019 in Chengdu, the organisation is one of two covered here that are based outside the eastern coastal cluster, the other being in Hunan.{{r|registry}} Its registered name includes "Peptide Biotech", making it one of the few whose registration matches its trading activity closely.
15Chengdu's position inland has a practical consequence that appears in purchaser reports: outbound shipments route through coastal or regional hubs, adding a domestic leg before the international one. Reported transit times have been slightly longer than for coastal comparators, and reported [[Temperature excursion|temperature exposure]] correspondingly greater on the temperature-sensitive lines.{{r|reports}}17Chengdu's position inland has a practical consequence that appears in purchaser reports: outbound shipments route through coastal or regional hubs, adding a domestic leg before the international one. Reported transit times have been slightly longer than for coastal comparators, and reported [[Temperature excursion|temperature exposure]] correspondingly greater on the temperature-sensitive lines.{{r|reports}}
1618
+19== Distribution and dispatch ==
+20The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.
+21
17== References ==22== References ==
18{{reflist}}23{{reflist}}
20<ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref>25<ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref>
21<ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref>26<ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref>
+27<ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref>
22<ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref>28<ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref>
2329